# Gilead Sciences, Inc.: Form 4, filed Feb 2, 2021

- Company: [Gilead Sciences, Inc.](/companies/gild.md) (CIK 882095)
- Form: 4
- Filed: 2021-02-02
- Accepted by EDGAR: Feb 2, 2021, 16:52 ET
- Period: 2021-01-31
- Accession: 0001104659-21-010972
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/882095/000110465921010972/xslF345X03/a4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882095/000110465921010972/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882095/000110465921010972/xslF345X03/a4.xml

Filed Feb 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-010972. Last ingested by Listed: Nov 6, 2026, 18:36 ET. No prices; not investment advice.